Temple-Smith Meredith, Sanci Lena
DHSc, MPH, BSc, is Associate Professor and Director, Research Training, General Practice, University of Melbourne, Victoria.
Aust Fam Physician. 2017 Oct;46(10):710-715.
The use of long-acting reversible contraceptives (LARCs) is globally accepted as a strategy that is successful in decreasing rates of unintended pregnancy, especially in very young women. Currently, Australia has very low uptake rates of LARC.
The aim of this paper is to explore the latest information on using LARCs as first-line contraception in young women.
Low uptake of LARCs may be related to Australia's prevailing cultural norm of oral contraception, and practitioner and patient misperceptions of the safety and efficacy of LARC, which have been dispelled in recent years. LARCs are widely recommended by professional bodies and the World Health Organization (WHO) as first-line contraception for young women as they are safe, effective and reversible. Young women should be offered the choice of a LARC as part of a fully informed decision for their first form of contraception.
长效可逆避孕法（LARC）的使用在全球范围内被公认为是一种成功降低意外怀孕率的策略，尤其是在非常年轻的女性中。目前，澳大利亚LARC的使用率非常低。
本文旨在探讨将LARC用作年轻女性一线避孕方法的最新信息。
LARC使用率低可能与澳大利亚普遍存在的口服避孕药文化规范，以及从业者和患者对LARC安全性和有效性的误解有关，而这些误解近年来已被消除。专业机构和世界卫生组织（WHO）广泛推荐LARC作为年轻女性的一线避孕方法，因为它们安全、有效且可逆。应该为年轻女性提供选择LARC的机会，作为她们首次避孕方式的充分知情决策的一部分。
